Publication | Open Access

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells

Significant ApoptosisMedicineApoptosisReceptor Tyrosine KinaseCell DeathAnti-cancer AgentPharmacologyCell BiologyCancer ResearchTumor BiologyTyrosine Kinase Ror1